We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RDTCF market cap is 23.12M. The company's latest EPS is CAD -0.0335 and P/E is -5.37.
| Year End 29 February 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 101k | 263k | 1.75M | 718k | 1.02M |
| Operating Income | -7.18M | -1.82M | -3.73M | -3.09M | -3.08M |
| Net Income | -7.96M | -2.3M | -8.49M | -3.81M | -4.31M |
| Year End 29 February 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 4.29M | 3.83M | 3.07M | 2.25M | 1.89M |
| Total Liabilities | 4.44M | 5.41M | 2.82M | 4.92M | 5.04M |
| Total Equity | -148k | -1.58M | 252k | -2.67M | -3.16M |
| Year End 29 February 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -3.03M | -1.62M | -3M | -864k | -2.3M |
| Investing | 530k | -9k | 1.86M | N/A | N/A |
| Financing | 1.24M | 1.65M | 1.13M | 857k | 2.43M |
| Market Cap | 23.12M |
| Price to Earnings Ratio | -5.37 |
| Price to Sales Ratio | 22.78 |
| Price to Cash Ratio | 138.46 |
| Price to Book Ratio | -7.32 |
| Dividend Yield | - |
| Shares Outstanding | 128.44M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 79.46% |
| 52 Week High | 0.39 |
| 52 Week Low | 0.0029 |
| Spread (Intraday) | 0.28 (99.86%) |
| Company Name | Rapid Dose Therapeutics Corp (PK) |
| Address |
1121 walker's line, unit 3a burlington, ontario L7N 2G4 |
| Website | https://www.rapid-dose.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
